Latest news, press releases, and SEC filings for Keros Therapeutics Inc (KROS) https://caymanjournal.com/stock/KROS en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:24:24 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 📜 What This Document Is 📜 This document is Keros Therapeutics, Inc.'s (KROS) definitive Proxy Statement for the 2026 Annual Meeting of Stockholders. Essentially, it is a formal annual report that tells you exactly what the company is doing, who is running it, and—most importantly—what decisions https://caymanjournal.com/stock/KROS/sec-filing/0001104659-26-046791 https://caymanjournal.com/stock/KROS/sec-filing/0001104659-26-046791 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing Please provide the actual content of the SEC filing. The input you provided is a placeholder structure (metadata) indicating that the document is an Annual Report Summary (ARS) for Keros Therapeutics, Inc., but the PDF content itself is empty. Once you provide the text or the full PDF, I will exec https://caymanjournal.com/stock/KROS/sec-filing/0001104659-26-046817 https://caymanjournal.com/stock/KROS/sec-filing/0001104659-26-046817 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing